HomeCompareQTS vs MRK

QTS vs MRK: Dividend Comparison 2026

QTS yields 15.65% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QTS wins by $9757330.19M in total portfolio value
10 years
QTS
QTS
● Live price
15.65%
Share price
$77.98
Annual div
$12.20
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9757330.24M
Annual income
$9,638,973,769,099.76
Full QTS calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — QTS vs MRK

📍 QTS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQTSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QTS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QTS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QTS
Annual income on $10K today (after 15% tax)
$1,329.83/yr
After 10yr DRIP, annual income (after tax)
$8,193,127,703,734.80/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, QTS beats the other by $8,193,127,695,406.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QTS + MRK for your $10,000?

QTS: 50%MRK: 50%
100% MRK50/50100% QTS
Portfolio after 10yr
$4878665.15M
Annual income
$4,819,486,889,448.95/yr
Blended yield
98.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

QTS
Analyst Ratings
18
Buy
11
Hold
Consensus: Buy
Price Target
$78.00
+0.0% upside vs current
Range: $78.00 — $78.00
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QTS buys
0
MRK buys
0
No recent congressional trades found for QTS or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQTSMRK
Forward yield15.65%2.76%
Annual dividend / share$12.20$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$9757330.24M$56.8K
Annual income after 10y$9,638,973,769,099.76$9,798.13
Total dividends collected$9749418.18M$28.9K
Payment frequencyquarterlyquarterly
SectorREITHealthcare
Analyst consensusBuyBuy
Analyst price target$78.00$128.54

Year-by-year: QTS vs MRK ($10,000, DRIP)

YearQTS PortfolioQTS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,829$3,129.01$11,206$366.19+$2.6KQTS
2$22,885$8,088.05$12,650$502.35+$10.2KQTS
3$49,505$25,017.94$14,407$694.19+$35.1KQTS
4$154,127$101,156.60$16,585$967.82+$137.5KQTS
5$753,583$588,667.43$19,342$1,363.89+$734.2KQTS
6$6,186,169$5,379,834.56$22,913$1,947.19+$6.16MQTS
7$89,167,030$82,547,829.43$27,662$2,823.89+$89.14MQTS
8$2,319,406,874$2,223,998,151.65$34,159$4,173.35+$2319.37MQTS
9$110,613,527,190$108,131,761,834.95$43,337$6,308.80+$110613.48MQTS
10$9,757,330,243,193$9,638,973,769,099.76$56,776$9,798.13+$9757330.19MQTS

QTS vs MRK: Complete Analysis 2026

QTSREIT

QTS Realty Trust, Inc. (NYSE: QTS) is a leading provider of data center solutions across a diverse footprint spanning more than 7 million square feet of owned data center space throughout primarily North America and Europe. Through its software-defined technology platform, QTS is able to deliver secure, compliant infrastructure solutions, robust connectivity and premium customer service to leading hyperscale technology companies, enterprises, and government entities. QTS owns, operates or manages 27 data centers and supports more than 1,200 customers primarily in North America and Europe.

Full QTS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this QTS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QTS vs SCHDQTS vs JEPIQTS vs OQTS vs KOQTS vs MAINQTS vs JNJQTS vs ABBVQTS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.